Staphylococcus aureus taşıyıcılığı üzerinde topical mometazon furoat burun spreyinin etkisi

Amaç: Bu çalışmada alerjik rinit tedavisinde Staphylococcus aureus S. aureus kolonizasyonu üzerinde topical mometazon furoat burun spreyinin etkisi araştırıldı.Hastalar ve Yöntemler: Ocak 2012 - Şubat 2013 tarihleri arasında uzun yıllardır alerjik rinit semptomları olan 53 hasta 37 kadın, 16 erkek ve 53 sağlıklı kontrol 36 kadın, 17 erkek çalışmaya alındı. Kulak Burun Boğaz polikliniğine başvuran alerjik rinit hastalarından burun kültürleri alındı ve tedaviden önce ve bir ay boyunca günde bir kez mometazon furoat burun spreyi ile tedaviden sonra değerlendirildi. Sağlıklı kontrollerde burun kültürleri yalnızca bir kez alındı ve değerlendirildi.Bulgular: Alerjik rinit hastalarında tedaviden önce beş kültür S. aureus pozitif iken, tedaviden sonra altı kültür S. aureus pozitifti. Tedavi öncesi ve sonrası S. aureus kolonizasyonu açısından hasta grubu ve kontroller arasında anlamlı bir fark yoktu p>0.05 .Sonuç: Alerjik rinit tedavisinde kullanılan mometazon furoat burun spreyinin burun S. aureus kolonizasyonu açısından etkisiz olduğu görülmektedir

The effect of topical mometasone furoate nasal spray on carriage of Staphylococcus aureus

Objectives: This study aims to examine the effect of topical mometasone furoate nasal spray on nasal Staphylococcus aureus S. aureus colonization in the treatment of allergic rhinitis. Patients and Methods: Between January 2012 and February 2013, 53 patients having perennial allergic rhinitis symptoms 37 females, 16 males and 53 healthy controls 36 females, 17 males were included in the study. Nasal cultures were obtained and evaluated before and after the treatment in allergic rhinitis patients who were admitted to the ear, nose and throat ENT outpatient clinic and receiving a mometasone furoate nasal spray treatment 200 mcg/day once a day for one-month. In healthy controls, nasal cultures were obtained and evaluated once. Results: In allergic rhinitis patients, five cultures were positive for S. aureus before the treatment while the number of cultures positive for S. aureus was six after the treatment. There was no significant difference in the pre-treatment and post-treatment S. aureus colonization between the patient group and controls p>0.05 . Conclusion: Mometasone furoate nasal spray used in the treatment of allergic rhinitis appears to be ineffective for nasal S. aureus colonization.

___

  • Howarth PH. Allergic and nonallergic rhinitis. In: Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER, editors. Allergy Principles and Practice. 6th ed. Philedelphia: Mosby; 2003. p. 1391-410.
  • Burr ML, Dean BV, Merrett TG, Neale E, St Leger AS, Verrier-Jones ER. Effects of anti-mite measures on children with mite-sensitive asthma: a controlled trial. Thorax 1980;35:506-12.
  • Storms WW. Treatment of seasonal allergic rhinitis with fluticasone propionate aqueous nasal spray: review of comparator studies. Allergy 1995;50(23 Suppl):25-9.
  • Minshall E, Ghaffar O, Cameron L, O’Brien F, Quinn H, Rowe-Jones J, et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998;118:648-54.
  • Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-20.
  • Gonlugur U, Akkurt I, Ozdemir L, Bakici MZ, Icagasioglu S, Gultekin F. Antibiotic susceptibility patterns of respiratory isolates of Staphylococcus aureus in a Turkish university hospital. Acta Microbiol Pol 2003;52:143-8.
  • Moreillon P, Que YA, Glauser MP. Staphylococcus aureus (including staphylococcal toxic shock). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's Principles and Practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005. p. 2321-51.
  • Karabay O, Arinc H, Gunduz H, Tamer A, Ozhan H, Uyan C. A new effect of acetylsalicylic acid? SigniŞcantly lower prevalence of nasal carriage of Staphylococcus aureus among patients receiving orally administered acetylsalicylic acid. Infect Control Hosp Epidemiol 2006;27:318-9.
  • Baker BS. The role of microorganisms in atopic dermatitis. Clin Exp Immunol 2006;144:1-9.
  • Baykam N, Esener H, Ergonul O, Kosker PZ, Cirkin T, Celikbas A, et al. Methicillin-resistant Staphylococcus aureus on hospital admission in Turkey. Am J Infect Control 2009;37:247-9.
  • von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001;344:11-6.
  • Erdenizmenli M, Yapar N, Senger SS, Ozdemir S, Yuce A. Investigation of colonization with methicillin- resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population in Turkey. Jpn J Infect Dis 2004;57:172-5.
  • Roll A, Cozzio A, Fischer B, Schmid-Grendelmeier P. Microbial colonization and atopic dermatitis. Curr Opin Allergy Clin Immunol 2004;4:373-8.
  • Sachs AP, van der Waaij D, Groenier KH, Koëter GH, Schiphuis J. Oropharyngeal flora in asthma and in chronic obstructive pulmonary disease. Indigenous oropharyngeal microorganisms in outpatients with asthma or chronic obstructive pulmonary disease. Am Rev Respir Dis 1993;148:1302-7.
  • Vázquez Nava F, Casados Robledo JS, Béltrán Guzmán FJ. Oropharyngeal bacterial flora in asthmatic and health subjects. Rev Alerg Mex 1998;45:31-5. [Abstract]
  • Graham PL 3rd, Lin SX, Larson EL. A US population- based of survey Staphylococcus aureus colonization. Ann Intern Med 2006;144:318-25.
  • Soysal A, Sahin H, Yagci A, Barlan I, Bakir M. The low rate of methicillin-resistant Staphylococcus aureus in Turkish children. Jpn J Infect Dis 2006;59:195-6.
  • Talay F, Karabay O, Yilmaz F, Kocoglu E. Effect of inhaled budesonide on oropharyngeal, Gram-negative bacilli colonization in asthma patients. Respirology 2007;12:76-80.
  • Tomic R, Lassiter CC, Ritzenthaler JD, Rivera HN, Roman J. Anti-tissue remodeling effects of corticosteroids: fluticasone propionate inhibits fibronectin expression in fibroblasts. Chest 2005;127:257-65.